In late June, Pfizer, the nation’s second-largest pharmaceutical supplier, broke ground on BioPlace, a $250 million, 285,000-sf R&D and process development facility in Chesterfield, Mo.
The new campus, when completed in mid 2019, will house the company’s BioTherapeutics Pharmaceutical Sciences Group, and consolidate more than 450 employees who currently work at multiple locations around St. Louis, including some who working out of leased space in Monsanto’s research center.
Pfizer intends to hire 80 more employees over the coming years to support research at this 32-acre site.
The 32-acre campus will allow Pfizer to consolidate more than 450 of its employees who are scattered at various leased sites around St. Lous. Image: Clayco
The focus of this facility, according to Pfizer’s website, will be on advancing the company’s portfolio in biologics, vaccines, and gene therapy by “developing manufacturing processes and dosage forms applying state-of-the-art analytical technologies.”
The campus will feature a floor plan with flexible laboratory layouts, scientific casework and utility hookups, open office and collaboration spaces, and increased conferencing technologies where researchers can collaborate.
A partnership of Forum Studio and Ewing Cole designed the architecture, landscaping, engineering, interior, and lab process areas for BioPlace’s research and office spaces. Clayco is the design-builder on this project in tandem with its development subsidiary CRG.
Once completed, Pfizer will lease the space from Clayco and CRG, which is providing turnkey build-to-suit services, according to the St. Louis Post-Dispatch.
Related Stories
| Aug 8, 2022
Mass timber and net zero design for higher education and lab buildings
When sourced from sustainably managed forests, the use of wood as a replacement for concrete and steel on larger scale construction projects has myriad economic and environmental benefits that have been thoroughly outlined in everything from academic journals to the pages of Newsweek.
Laboratories | Jul 17, 2022
Renovation is filling the need for life sciences lab space
Three experts from the firm DiMella Shaffer discuss the advantages and challenges of converting existing buildings.
Laboratories | Jun 29, 2022
The "collaboratory" brings digital innovation to the classroom
The Collaboratory—a mix of collaboration and laboratory—is a networking center being designed at the University of Denver’s College of Business.
Museums | Jun 28, 2022
The California Science Center breaks grounds on its Air and Space Center
The California Science Center—a hands-on science center in Los Angeles—recently broke ground on its Samuel Oschin Air and Space Center.
University Buildings | Jun 7, 2022
Newfoundland university STEM building emulates natural elements, local traditions
Memorial University of Newfoundland (MUN) recently opened a new building that will provide interdisciplinary learning and research space for Faculties of Science and Engineering.
Laboratories | May 20, 2022
Brutalist former Berkeley Art Museum transformed into modern life science lab
After extensive renovation and an addition, the former Berkeley Art Museum and Pacific Film Archive at the University of California, Berkeley campus reopened in May 2022 as a modern life science lab building.
Laboratories | Apr 29, 2022
Oracle Industry Lab in Chicago enables development of solutions for multiple industries
The Oracle Industry Lab in Chicago, which provides customers in multiple industries the opportunity to test new technologies, recently opened.
Laboratories | Apr 7, 2022
North Carolina's latest play for biotech real estate development
The Tar Heel State is among a growing number of markets rolling out the welcome mat for lab spaces.
Projects | Mar 11, 2022
Studying science in the sky
In sharp contrast to other types of commercial real estate, the life sciences market is booming, according to SGA, an architecture firm based in Boston and New York that has extensive experience designing life sciences buildings.
Laboratories | Feb 10, 2022
Historic building becomes a research science incubator
Svigals + Partners designed the project.
